BACE1 and Alzheimer disease: The pathological hallmark of AD, amyloid plaques40,41 derived from BACE1-cleaved APP, were significantly decreased in number and size of foci in the hippocampus and cortex of VIP@siBACE1-treated APP/PS1 mice (Fig. 5d, e).